News > Longevity 2020How to identify new targets and indications for aging drug development

How to identify new targets and indications for aging drug development

Author:  |  Published on: April 30, 2020  |  Last updated: May 10, 2022

Simon Melov

Professor, Buck Institute and Founder and CEO, Gerostate Alpha

How to identify new targets and indications for aging drug development


 

Editor's choice

‘Data-driven health is going to be the biggest revolution in the history of medicine’

Leveraging the past to illuminate longevity for the future

‘It’s always too early to say something’s impossible’

‘Longevity is the biggest revolution in the history of Homo sapiens – don’t die!’

Calling all longevity clinicians: your voice matters!

Combining AI and MRI to improve human longevity

Popular articles

Longevity investment bulletin: NewLimit, ORA, Insilico Medicine and more

Stay cool: the longevity tech that “shows insane promise”

Does SIRT6 hold the key to human longevity?

Tally up! Consumer longevity company lands $10m

Longevity: ‘money-spinning cult’ or the future of health?

Zuzalu: a pop-up city with longevity at its heart

More like this

‘I want medical tourism to be open to everyone, forever’

Features

‘We are information machines – and it’s time to renew the code.’

Investment

‘It’s always too early to say something’s impossible’

Videos

‘We’re at the longevity inflection point – and the explosion is coming.’

Features

Longevity to a sirtuin extent

Videos

‘Longevity is the biggest revolution in the history of Homo sapiens – don’t die!’

Features

Longevity: This time it’s personal

Supplements

SIRT6: The protein that talks the talk and walks the walk

Videos

Navigate the emerging field of longevity

Economy

It’s a brave new world – but longevity needs to stay in the realm of the credible

Economy

Unlocking longevity potential: GlycanAge’s approach to longevity, healthspan and menopause

Diagnostics

A strong patent portfolio delivers a competitive edge in the longevity space

Investment

Juvenescence: Think aging up, rather than disease down

Features

Combilytics: Taking a combined approach to senescence

Supplements

Investing in Longevity 101

Economy

Getting comfortable with senotherapeutics

Biotech